Micotar

Miconazole, the active ingredient in Micotar, is an imidazole antifungal presented as a buccal formulation for buccal use. It treats oral candidiasis by eradicating Candida species and relieving symptoms such as soreness, burning, and altered taste. The buccal delivery provides direct contact with the oral mucosa, offering localized antifungal activity while limiting systemic exposure.

GNH USA supplies Micotar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU GMP standards and provides reliable logistics for global distribution.

Micotar (miconazole) is used to treat fungal infections of the oral cavity.

Oral candidiasis: reduces fungal growth and relieves soreness, burning and taste disturbances. Denture‑associated stomatitis: helps control Candida overgrowth on denture surfaces. Oropharyngeal candidiasis: treats infection that extends to the throat.

Miconazole buccal preparations are generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Altered taste or metallic taste. - Mild oral irritation or burning sensation. - Nausea or mild gastrointestinal discomfort. - Dry mouth. - Localized itching or redness.

Serious or Rare Side Effects: - Severe allergic reactions including rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction manifested by jaundice or elevated liver enzymes. - Unexplained fever or systemic symptoms. - Persistent or worsening oral lesions.

Before using Micotar, consider the following safety measures. - Hypersensitivity assessment: avoid if known allergy to miconazole or other imidazoles. - Liver function: use with caution in patients with hepatic impairment. - Drug interactions: review concomitant medications that affect CYP450 enzymes. - Extent of use: limit application to the prescribed area to reduce systemic absorption. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Miconazole may interact with other medicines; monitor as indicated.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic exposure. - Systemic azole antifungals: additive toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in anticoagulant effect. - Rifampin or other CYP inducers: may reduce miconazole efficacy. - Oral contraceptives: possible reduction in hormonal effectiveness. - Antacids containing aluminum or magnesium: may affect absorption.